JAMA8 Mar 2024
After 7 to 12 years of follow-up, individuals who underwent bariatric surgery instead of medical/lifestyle intervention showed superior glycemic control, requiring fewer diabetes medications, and experiencing higher rates of diabetes remission. An average HbA1c decrease of 1.4% at 7 years and 1.1% at 12 years…
Metabolic and Bariatric Surgery8 Mar 2024
The combined use of transient elastography (te) and visual liver score (vls) in assessing non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery showed high sensitivity and diagnostic accuracy. Transient elastography with a visual liver score is comparable…
Obes Surg5 Mar 2024
Simulation of 20,000 obese patients with non-alcoholic steatohepatitis found that sleeve gastrectomy (SG) led to a gain of 14.3 years compared to medical weight management (MWM), with only 5% of SG patients requiring liver transplantation (LT) after one year, compared to 9% in the MWM…
J Am Coll Surg4 Mar 2024
Same-day discharge (SDD) after bariatric operation has increased from 2.4% in 2016 to 7.4% in 2021. The study found that black/African American race, history of myocardial infarction, renal insufficiency, DVT, and smoking were preoperative factors associated with increased complications for SDD. SDD for RYGB had…
Metabolic and Bariatric Surgery4 Mar 2024
After metabolic and bariatric surgery, 74% of patients achieved remission of obesity-related sleep apnea, which was associated with significantly lower risks of overall mortality and major cardiovascular events compared to those who did not reach remission. The risk for death and cardiovascular events in the…
Obes Surg3 Mar 2024
Patients who developed small bowel obstruction (SBO) after bariatric surgery were older, with lower BMI, and more likely female. Serious complications at 30 days post-operation were increased in SBO patients, with Roux-en-Y gastric bypass being the largest independent predictor of SBO development. COPD, prior DVT,…
Obes Surg3 Mar 2024
After bariatric surgery, attention capacity and executive function improved, while immediate memory worsened. Serine, glutamic acid, and glycolic acid were identified as potential metabolites linked to cognitive performance alterations. Cluster analysis revealed two subgroups, with cluster 2 showing improved attention and executive function but reduced…
Obes Surg2 Mar 2024
Comparing outcomes of primary single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) to two-stage SADI-S after sleeve gastrectomy (SG), a Canadian bariatric study with 179 laparoscopically treated patients (2016โ2020) revealed both approaches as efficient in achieving weight loss and comorbidity reduction at short and mid-term…
Obes Surg29 Feb 2024
Researchers compared laparoscopic sleeve gastrectomy (LSG) with laparoscopic Roux-en-Y gastric bypass (LRYGB) in treating obesity. The meta-analysis of 20 studies involving 1270 patients showed that LRYGB was superior to LSG in terms of BMI loss at six months and short-term T2DM remission efficacy. However, LSG…
J Am Coll Surg28 Feb 2024
Roux-en-Y gastric bypass (RYGB) patients display higher rates of continued diabetes remission (CDR) compared to sleeve gastrectomy (SG) patients, even with weight recurrence (WR). The odds of Type 2 diabetes mellitus (T2DM) recurrence were 5.5 times higher in the SG group. Baseline insulin use, higher…